Company overview
Cresset provides digital molecular discovery solutions powered by advanced simulation science and AI for pharmaceutical R&D. Their flagship Flare platform accelerates small molecule discovery, enabling researchers to design and predict novel molecules efficiently. These tools reduce time and costs in drug discovery workflows globally.
Better molecules, by design - Cresset is listed in the NovaPharmaNews Supplier Hub as a Software & Digital Lab partner serving United States & Americas. Core focus areas include cresset, flare software, digital molecular discovery, ai drug design, cadd platform.
Industry categories: Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Better molecules, by design - Cresset include Software — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.cresset-group.com
- Categories
- Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- cresset, flare software, digital molecular discovery, ai drug design, cadd platform
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is Cresset's main software platform?
- Flare is Cresset's flagship CADD platform that combines cutting-edge science with AI/ML to empower small molecule discovery, design, and activity prediction.
- How does Cresset incorporate AI in drug discovery?
- Cresset enriches validated simulation science with focused AI use, including AI agents for protein preparation, docking simulations, and workflow orchestration to enhance efficiency.
- What industries does Cresset serve?
- Cresset serves global pharmaceutical and biotech researchers focused on accelerating small molecule drug discovery and digital chemistry workflows.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
